Physician profile
Matthew Jones
NPI 1831639764
$4,820.10
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $272 · 2022: $2,689 · 2023: $41.24 · 2024: $1,610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $866 · Travel and Lodging: $776 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $866.08 |
| Travel and Lodging | $776.20 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,960.17 | 2022-2024 | Da Vinci Surgical System |
| Musculoskeletal Transplant Foundation INC. | $271.92 | 2020 | |
| Kci USA, INC. | $211.67 | 2019-2023 | V.A.C. Veraflo, V.A.C.Ulta, V.A.C. Ats |
| Evoke Pharma, INC. | $75.26 | 2024 | |
| Abbvie INC. | $53.37 | 2024 | |
| Lilly USA, LLC | $51.25 | 2024 | Omvoh |
| Takeda Pharmaceuticals U.S.A., INC. | $47.05 | 2024 | Entyvio |
| Janssen Biotech, INC. | $34.22 | 2024 | Simponi Aria, Tremfya, Stelara |
| Phathom Pharmaceuticals, INC. | $30.33 | 2024 | Voquezna |
| Smith+Nephew, INC. | $26.24 | 2024 | Stravix |
| Ethicon US, LLC | $16.81 | 2019 | |
| Ardelyx, INC. | $16.67 | 2024 | Ibsrela |
| Qol Medical, LLC | $13.14 | 2024 | Sucraid |
| Polynovo North America LLC | $12.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.